Henry Schein, Inc. $HSIC Shares Acquired by Adage Capital Partners GP L.L.C.

Key Points

• Adage Capital Partners GP L.L.C. increased its stake in Henry Schein, Inc. by 16.8% in Q1, owning 572,455 shares valued at approximately $39.2 million as of their latest SEC filing.
• Henry Schein reported Q2 earnings of $1.10 per share, missing the consensus estimate of $1.19, despite a year-over-year revenue increase of 3.3% to $3.24 billion.
• Analyst ratings for Henry Schein are mixed, with five analysts rating the stock as a "Buy" and seven as a "Hold," while the consensus price target is set at $76.67.

Adage Capital Partners GP L.L.C. raised its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 16.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 572,455 shares of the company's stock after acquiring an additional 82,142 shares during the quarter. Adage Capital Partners GP L.L.C. owned approximately 0.47% of Henry Schein worth $39,207,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC grew its holdings in shares of Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after purchasing an additional 1,898 shares during the period. State of Alaska Department of Revenue grew its holdings in shares of Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after purchasing an additional 395 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in shares of Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after purchasing an additional 678 shares during the period. GAMMA Investing LLC grew its holdings in shares of Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after purchasing an additional 1,081 shares during the period. Finally, Zuckerman Investment Group LLC grew its holdings in shares of Henry Schein by 69.6% during the 1st quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company's stock worth $13,810,000 after purchasing an additional 82,779 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Ratings Changes

Several analysts have recently issued reports on HSIC shares. Robert W. Baird reissued a "neutral" rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Barrington Research reduced their price target on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 6th. JPMorgan Chase & Co. reduced their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Finally, Leerink Partners set a $75.00 price target on Henry Schein in a research report on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, Henry Schein currently has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Performance

NASDAQ:HSIC traded down $1.69 during mid-day trading on Monday, reaching $67.74. 1,512,656 shares of the stock were exchanged, compared to its average volume of 1,751,952. The company has a 50 day simple moving average of $69.92 and a 200-day simple moving average of $69.68. The stock has a market capitalization of $8.21 billion, a P/E ratio of 21.85, a P/E/G ratio of 2.29 and a beta of 0.86. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company's quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.